Pralsetinib HCl (2097132-94-8 free base) TQ0277L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Pralsetinib is a selective and next-generation RET inhibitor (IC50: 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T, and CCDC6-RET fusion). BLU-667 is an effective and selective inhibitor of RET mutations, fusions, and predicted resistant mutants.
CAS nr:
TQ0277L
Purity:
98%
Molecular Weight:
570,07
SMILES:
O=C([C@@]1(OC)CC[C@@H](C2=NC(NC3=NNC(C)=C3)=CC(C)=N2)CC1)N[C@H](C4=CC=C(N5N=CC(F)=C5)N=C4)C.[H]Cl
Formula:
C27H33ClFN9O2
Pathway:
Target:
